Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
Clave E, Agbalika F, Bajzik V, Peffault de Latour R, Trillard M, Rabian C, Scieux C, Devergie A, Socié G, Ribaud P, Adès L, Ferry C, Gluckman E, Charron D, Esperou H, Toubert A, Moins-Teisserenc H. Clave E, et al. Transplantation. 2004 Jan 15;77(1):76-84. doi: 10.1097/01.TP.0000093997.83754.2B. Transplantation. 2004. PMID: 14724439
Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
Konopacki J, Porcher R, Robin M, Bieri S, Cayuela JM, Larghero J, Xhaard A, Andreoli AL, Dhedin N, Petropoulou A, Rodriguez-Otero P, Ribaud P, Moins-Teisserenc H, Carmagnat M, Toubert A, Chalandon Y, Socie G, Peffault de Latour R. Konopacki J, et al. Haematologica. 2012 May;97(5):710-6. doi: 10.3324/haematol.2011.050096. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180425 Free PMC article.
Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation.
Petropoulou AD, Porcher R, Peffault de Latour R, Xhaard A, Weisdorf D, Ribaud P, Rodriguez-Otero P, Agbalika F, Talbot A, Toubert A, Moins-Teisserenc H, Carmagnat M, Socié G, Robin M. Petropoulou AD, et al. Transplantation. 2012 Oct 27;94(8):879-83. doi: 10.1097/TP.0b013e3182664042. Transplantation. 2012. PMID: 23001354
Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
Servais S, Lengline E, Porcher R, Carmagnat M, Peffault de Latour R, Robin M, Sicre de Fontebrune F, Clave E, Maki G, Granier C, Xhaard A, Dhedin N, Molina JM, Toubert A, Moins-Teisserenc H, Socie G. Servais S, et al. Biol Blood Marrow Transplant. 2014 Apr;20(4):507-17. doi: 10.1016/j.bbmt.2014.01.001. Epub 2014 Jan 7. Biol Blood Marrow Transplant. 2014. PMID: 24406505 Free article.
Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT.
Xhaard A, Moins-Teisserenc H, Busson M, Robin M, Ribaud P, Dhedin N, Abbes S, Carmagnat M, Kheav VD, Maki G, Peffault de Latour R, Toubert A, Socié G. Xhaard A, et al. Bone Marrow Transplant. 2014 Aug;49(8):1089-92. doi: 10.1038/bmt.2014.105. Epub 2014 May 19. Bone Marrow Transplant. 2014. PMID: 24842524 Clinical Trial.
80 results